Lupin aims to be numero uno in biosimilar etanercept in JapanIt takes 12-13 months for the Japanese drug authorities to give product approvals.
22 Jun, 2018, 02.09 PM IST
Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in JapanMumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...
18 Jun, 2018, 11.59 AM IST
Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brandsThe acquisition will result in a wider offering for Lupin in Japanese market where its sales last fiscal stood at Rs 1,364 crore.
27 Jul, 2016, 05.27 AM IST
Sun Pharma’s Novartis deal could be a bright spotSun Pharma’s acquisition of 14 established prescription brands of Swiss drug maker Novartis in Japan will give it a headstart in the $73 bi...
01 Apr, 2016, 09.15 AM IST
Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest growing listThe club of the fastest growing generic companies in the world is dominated by US companies , led by US-based Sagent Pharma, which witnesse...
30 Aug, 2012, 08.58 AM IST